Written by Dr Fasihul Khan, Consultant Respiratory Physician and ILD specialist, providing expert guidance on interstitial lung disease.
Key points
-
Pulmonary fibrosis means scarring within the lungs, but it is not a single disease
-
The condition can behave very differently and some patients remain stable for many years
-
Symptoms most commonly include breathlessness and a persistent dry cough
-
Diagnosis depends on CT imaging, lung function, and clinical context, not a single test
-
Treatment is tailored to the individual and aims to slow progression and manage symptoms over time
What is pulmonary fibrosis?
Pulmonary fibrosis refers to scarring within the lungs. This scarring makes the lungs stiffer and less able to transfer oxygen effectively, which can lead to symptoms such as breathlessness and cough. Being told you have pulmonary fibrosis can feel overwhelming, particularly as the term is often associated with uncertainty about the future. However, it is important to recognise that pulmonary fibrosis is not a single disease, and its behaviour can vary significantly between individuals.
How does pulmonary fibrosis relate to ILD?
Pulmonary fibrosis sits within a broader group of conditions known as interstitial lung disease (ILD). In some cases, a clear cause can be identified, such as autoimmune disease, environmental exposures, or previous lung inflammation. In others, no cause is found, and the condition may be classified as idiopathic pulmonary fibrosis. Even within the same diagnostic category, the way the disease behaves over time can differ substantially, which is why careful assessment and follow-up are essential.
What symptoms does it cause?
Symptoms most commonly include breathlessness, often first noticed during exertion, and a persistent dry cough. Fatigue and reduced exercise tolerance are also frequent. These symptoms typically develop gradually and may initially be attributed to ageing or reduced fitness. In some patients, pulmonary fibrosis is identified incidentally on imaging performed for another reason, before significant symptoms have developed.
How is it diagnosed?
Diagnosis is based on a combination of clinical assessment, imaging, and lung function testing. A CT scan of the chest plays a central role, alongside blood tests and a detailed review of symptoms, occupational and environmental exposures, and medical history. In many cases, a confident diagnosis can be reached without invasive testing. Where uncertainty exists, cases may be discussed within a specialist multidisciplinary team to ensure accurate classification.
Does pulmonary fibrosis always get worse?
One of the most important aspects of pulmonary fibrosis is understanding how the disease behaves over time. Not all fibrosis progresses. Some patients remain stable for prolonged periods, while others show gradual change. A single scan or lung function test does not define the overall trajectory. Instead, patterns emerge through structured monitoring, including repeated lung function measurements, symptom assessment, and, where appropriate, follow-up imaging.
What treatments are available?
Treatment is guided by both the underlying diagnosis and disease behaviour. In fibrotic conditions where progression is evident or anticipated, anti-fibrotic therapies may be used to slow the rate of decline. In conditions where inflammation plays a more prominent role, immunosuppressive treatment may be appropriate. Supportive strategies such as pulmonary rehabilitation, optimisation of general health, and, in selected cases, oxygen therapy can also make a meaningful difference to symptoms and quality of life. Management is individualised and reviewed over time.
What is the outlook?
Understandably, many patients are concerned about prognosis. While pulmonary fibrosis can be a serious condition, outcomes vary widely. Some individuals experience slow change over many years, while others require closer monitoring and earlier intervention. Prognosis is best understood through observation of disease behaviour over time rather than at the point of diagnosis. For this reason, ongoing follow-up is a central part of care.
When is specialist review helpful?
Because pulmonary fibrosis encompasses a range of different conditions, careful interpretation of imaging, lung function trends, and clinical context is essential. Small differences in assessment can influence diagnosis, prognosis, and treatment decisions. Specialist respiratory review can therefore be particularly helpful when the diagnosis is uncertain, when treatment is being considered, or when there are concerns about progression.
Pulmonary fibrosis is a complex condition, but it is not defined by a single pathway or outcome. With accurate diagnosis, structured monitoring, and appropriate treatment, many patients achieve stability and maintain a good quality of life. If you have been diagnosed with pulmonary fibrosis or would like help understanding your condition in more detail, a specialist consultation can provide clarity and guide the next steps.